Skip to Content

ACIP Issues 2021 Immunization Schedule for Adults

FRIDAY, Feb. 12, 2021 -- The recommended immunization schedule for adults has been updated for 2021, according to a report published online Feb. 11 in the Annals of Internal Medicine and in the Feb. 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Mark S. Freedman, D.V.M., from the CDC in Atlanta, and colleagues present the 2021 adult immunization schedule, which summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations.

The 2021 immunization schedule includes several changes from the 2020 schedule on the coverage page, two tables, and accompanying notes. Vaccine-specific changes include new or updated ACIP recommendations for influenza vaccine, hepatitis A vaccine, hepatitis B vaccine, human papillomavirus vaccine, pneumococcal vaccines, meningococcal serogroups A, C, W, and Y vaccines, meningococcal B vaccines, and zoster vaccine. In addition, a section has been added for COVID-19 vaccine recommendations, following interim recommendations for use of Pfizer-BioNTech and Moderna COVID-19 vaccines after emergency use authorization by the U.S. Food and Drug Administration. Other updates include changes to Table 2 to indicate that the measles, mumps, and rubella vaccine should be administered after pregnancy; the varicella vaccine should be administered after pregnancy; and the zoster vaccine live or Zostavax vaccine has been removed since it is no longer available in the United States.

"For further guidance on the use of each vaccine, including contraindications and precautions, and any updates that might occur between annual updates to the adult immunization schedule, health care providers are referred to the respective ACIP vaccine recommendations," the authors write.

Annals of Internal Medicine

Morbidity and Mortality Weekly Report

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Racial/Ethnic Minorities Underrepresented in Vaccine Trials

THURSDAY, Feb. 25, 2021 -- There is underrepresentation of racial/ethnic minorities and older patients among U.S.-based vaccine clinical trials, while female adults are...

FDA Review Reveals J&J COVID-19 Vaccine Safe, Effective

WEDNESDAY, Feb. 24, 2021 -- A single-shot COVID-19 vaccine made by Johnson & Johnson completely prevented hospitalizations and deaths in a large clinical trial, according to...

Nationwide Study Shows BNT162b2 mRNA Vaccine Is Effective

WEDNESDAY, Feb. 24, 2021 -- The BNT162b2 mRNA vaccine is effective for COVID-19-related outcomes, including hospitalization, severe illness, and death, in a nationwide, mass...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.